We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Teledyne Technologies
TDY
$32B
| $13M | 0.03% |
41,800
-1,300
| -3% | -$410K |
|
477
Lockheed Martin
LMT
$136B
| $12.9M | 0.03% |
33,785
-96,415
| -74% | -$36.8M |
|
478
Royal Caribbean
RCL
$85.6B
| $12.9M | 0.03% |
199,500
+9,300
| +5% | +$548K |
|
479
Pultegroup
PHM
$25.3B
| $12.9M | 0.03% |
278,600
-9,700
| -3% | -$415K |
|
480
uniQure
QURE
$3.22B
| $12.9M | 0.03% |
350,000
-50,000
| -13% | -$2.05M |
|
481
Astec Industries
ASTE
$1.02B
| $12.9M | 0.03% |
237,511
+19,709
| +9% | +$986K |
|
482
Evergy
EVRG
$19.2B
| $12.8M | 0.03% |
252,305
-1,055,795
| -81% | -$59M |
|
483
JFrog
FROG
$10.8B
| $12.7M | 0.03% |
+150,000
| New | +$11.2M |
|
484
Oneok
OKE
$54.5B
| $12.6M | 0.03% |
486,500
+19,800
| +4% | +$551K |
|
485
eBay
EBAY
$49.8B
| $12.6M | 0.03% |
242,200
-526,600
| -68% | -$29M |
|
486
Wabtec
WAB
$49.3B
| $12.6M | 0.03% |
203,235
-6,865
| -3% | -$440K |
|
487
Pool Corp
POOL
$7.5B
| $12.6M | 0.03% |
+37,543
| New | +$11.6M |
|
488
Ingersoll Rand
IR
$33.7B
| $12.5M | 0.03% |
351,803
+336,600
| +2,214% | +$11.3M |
|
489
Atmos Energy
ATO
$28.8B
| $12.5M | 0.03% |
130,465
-4,500
| -3% | -$449K |
|
490
Tyler Technologies
TYL
$12.8B
| $12.4M | 0.03% |
35,500
-8,900
| -20% | -$3.08M |
|
491
Bio-Rad Laboratories Class A
BIO
$9.42B
| $12.4M | 0.03% |
24,000
+18,200
| +314% | +$9.22M |
|
492
Sea Limited
SE
$69.5B
| $12.3M | 0.03% |
+80,000
| New | +$10.8M |
|
493
Gartner
IT
$11.7B
| $12.3M | 0.03% |
98,400
+11,800
| +14% | +$1.5M |
|
|
NOVA
494
DELISTED
Sunnova Energy
NOVA
| $12M | 0.03% |
395,253
-204,747
| -34% | -$4.85M |
|
|
PSTX
495
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $12M | 0.03% |
+1,350,268
| New | +$15.4M |
|
|
TCF
496
DELISTED
TCF Financial Corporation Common Stock
TCF
| $11.9M | 0.03% |
511,421
-234,959
| -31% | -$6.29M |
|
|
CSII
497
DELISTED
Cardiovascular Systems, Inc.
CSII
| $11.8M | 0.03% |
+300,000
| New | +$9.69M |
|
498
Avery Dennison
AVY
$13.4B
| $11.8M | 0.03% |
92,100
-203,304
| -69% | -$24M |
|
499
Bath & Body Works
BBWI
$4.1B
| $11.7M | 0.03% |
454,118
-10,514
| -2% | -$215K |
|
|
RWT
500
Redwood Trust
RWT
$594M
| $11.6M | 0.03% |
1,548,485
+297,920
| +24% | +$2.11M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.